Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
Philip ClinganRahul LadwaDaniel BrungsDean Laurence HarrisMargaret McGrathSusan ArnoldJermaine CowardSamuel FourieAndriy KurochkinDaniel R MalanAndrew MantVinay SharmaHong ShueAndrea TazbirkovaMiguel-Angel Berciano-GuerreroChaiyut CharoentumStéphane DalleArunee DechaphunkulOleksandr DudnichenkoPiotr KoralewskiIwona LugowskaHenri MontaudiéEva Muñoz-CouseloVirote SriuranpongJames OlivieroJayesh DesaiPublished in: Journal for immunotherapy of cancer (2023)
NCT03212404.